Our Terms of Use and Privacy Policy have changed. We think you'll like them better this way.

Innovative CRISPR-based Editing to Create Off-the-shelf Immune Cell Therapies

  • Broadcast in Science
Pharma Talk Radio

Pharma Talk Radio


Follow This Show

If you liked this show, you should follow Pharma Talk Radio.

In this talk, first recorded at the 2022 IO360° Summit, Dr Rachel Haurwitz, CEO, Caribou Biosciences, addresses the big picture view of where the cell therapy field is going and how innovative CRISPR-based editing will help with the treatment of hematologic and solid tumors. Key topics include:

  • Approach that requires highly specific and efficient multiplex genome editing
  • What are some of the potential stumbling blocks?
  • What are the tools for solving those challenges?
  • Tackling solid tumors as the next frontier for cell therapies

Rachel Haurwitz, PhD, President & CEO, Caribou Biosciences

Learn more about the IO360° Summit at www.io360summit.com

Facebook comments

Available when logged-in to Facebook and if Targeting Cookies are enabled